Immuneering CorporationIMRXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
17.55%
↑ 132% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-55.55%
Historical baseline
PeriodValue
202517.55%
2024-12.32%
2023-11.04%
2022-42.95%
2021-111.01%
2020-229.11%
20190.00%